随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
type: 'bytes',。heLLoword翻译官方下载对此有专业解读
。爱思助手下载最新版本是该领域的重要参考
「像鬼一樣工作」：台灣外籍移工為何陷入「強迫勞動」處境
Samsung has officially unveiled the Galaxy S26, Galaxy S26+ and Galaxy S26 Ultra, and the company is once again leaning heavily on AI, camera upgrades and refined hardware to move the lineup forward. While the overall design remains familiar, there are some meaningful differences between the three models, particularly when it comes to display tech, charging speeds and camera hardware.。关于这个话题，heLLoword翻译官方下载提供了深入分析
Couple to re-start trek around Britain's coastline